 SOLANA BEACH, Calif., June 01, 2022 GLOBE NEWSWIRE -- Artelo Biosciences, Inc. Artelo or the Company NASDAQ: ARTL, a clinical-stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting at the LD Micro conference which is being held on June 7 9, 2022, at the Four Seasons Westlake Village, California. 